"We request your participation in a telebriefing about updates on NIH’s efforts to advance research on ME/CFS. The telebriefing will be held on November 28, 2017, 1:00 until 2:00 pm ET. If you will be calling from the U.S., please use the following dial-in information for the telebriefing.

Dial-in: 877-951-7311Participant passcode: 8394694If you will be calling from another country, please see the attached chart for your country’s access information.

Please remember to register at NIHME CFSWorkingG@ninds.nih.gov if you plan to participate in the call.

Thank you in advance for your participation and we look forward to an engaging, thoughtful and productive conversation.

The IACFS/ME (International Association for CFS and ME) Conference is held every other year. This year it was held on October 27-30, at the Westin Fort Lauderdale Beach Resort in Fort Lauderdale, Florida.

This conference is a huge event, attracting researchers and clinicians from all over the world. There are workshops, presentations, poster sessions and numerous networking events. It is an exciting gathering, and a wonderful opportunity to hear the latest in ME/CFS research.

Traditionally, Dr. Komaroff gives a summary of the notable research presented at the conference. ​Mary Schweitzer has generously provided the summary below with this note: This is my best effort of transcribing Komaroff’s summary of the 2016 meeting - feel free to repost.

-----------------------------------------------------------

Komaroff summary of 2016 IACFS/ME meeting

In the past two years, since the 2014 SF meeting the report of the IOM based on a review of other 9.000 published articles concludes that ME/CFS is a “biologically-based illness”

Announcement of expanded research activities by the National Institutes of Health and educational efforts by the Centers for Disease Control and Prevention.

Detailed analysis of the components of “post-exertional malaise” (Stanford)- Physical and cognitive exertion trigger PEM more often than emotional distress.- PEM includes not only fatigue, but also cognitive difficulties, sleep disturbances, headaches, muscle pain and flu-like symptoms- PEM lasts 3 or more days in approximately 25% of people.

Exercise testing in patients with ME?CFS vs. healthy controls:- Triggers a characteristic gene expression “signature” involving 15 cytokines/adipokines/growth factors (Stanford)- When repeated 24 hours after a first exercise test leads to a significant decline in peak heart rate (“chronotropic incompetence”), which could contribute to post-exertional malaise (U of the Pacific)- Leads to postural tachycardia after exercise (as contrasted to after tilt table testing) in a subset of ME/CFS patients and Gulf War Illness patients, due to increased sympathetic activity (Georgetown)

Exercise testing in patients with ME/CFS vs. healthy control subjects:- Leads to lower oxygen consumption and earlier conversion to anaerobic metabolism (Nova and Wisconsin)- Blood lactate levels in 2nd exercise test after 24 hours- ME/CFS patients lactate levels are higher at all work loads- Healthy controls: lactate leels are lower at all work loads.

Immunology:

Huge study: 192 cases, 392 healthy controls.- Levels of 17/51 cytokines/adipokines/growth factors were significantly different in ME/CFS than healthy controls- Most of the cytokines were pro-inflammatory, and their levels correlated significantly with the severity of symptoms (Stanford University)

Interesting because many clinicians and researchers in this field have long believed that the disease was caused by abnormal cytokines in the brain.

- Synthesize molecules of inflammation (cytokines, prostaglandins) and elicit the production of those molecules by the gut immune system- Through inflammation, create a “leaky gut”: the tight junctions that bind gut epithelia cells together become loosened – allowing bacteria and bacterial toxins to enter the blood.

In addition to the recently-reported reduction in bacterial diversity in ME/CFS, the team reports finding an increased number of Caudovirales bacteriophage viruses in ME/CFS.

All of these findings point to low-level inflammation in the gut. (Cornell)

--------------

Brain and Nervous System

- Impaired speed in processing information is shown to be a critical deficit in both ME/CFS and Gulf War Illness- Compared to healthy children, pediatric patients with ME/CFS had impaired information processing speed and attention. After exertion, these deficits worsened and ME/CFS kids also had poorer performance on tasks of working memory.- Impairments in cerebral blood flow and cortical glutathione levels – not affected by comorbid psychiatric disease.- A third of ME/CFS, but no healthy controls, had high white cell count or elevated protein in spinal fluid.- Altered heart rate variability, due to reduced cardiac vagal activity, in ME/CFS v. healthy controls. [There is some evidence that this can be a sign or contributory factor to heart disease later.]

Functional connectivity among different brain regions impaired:- Followed a cognitive test in ME/CFS v. healthy controls, determined by PET- As determined by diffusion MRI in GWI patients- As determined by EEG (eLORETTA) in ME/CFS patients at rest

----------------

Epigenetic studies- Disease is caused not just by mutated genes- It also is caused by perfectly normal, non-mutated genes, when those genes are not “expressed” (turned on or off) appropriately- Gene expression is controlled by many different “epigenetic” forces- Epigenetic studies are increasingly being done in ME/CFS v. healthy control- ME/CFS: genes involved in signal transduction are hypomethylated more often, whereas genes involved in cell differentiation/cell death are hypermethylated more often- ME/CFS: significantly different gene expression patterns for genes, involved in immune regulation (JAK-STAT pathway), hormone regulation and mitochondrial dysfunction.- Gulf War Illness: 19 related groups of genes (“functional modules”) were found to have significantly altered gene expression. Specific immunosuppressant and hormonal therapies were identified that might target these dysregulated genes, and possibly improve symptoms.- ME/CFS patients, compared to healthy controls, have 13 different gene loci, all involving glucocorticoid sensitivity that are differentially methylated. The different methylation patterns correlated with clinical symptoms- Characteristic expression of two particular microRNAs in plasma leads to elevated homocysteine levels identified in ME/CFS- Three SNPs distinguished ME/CFS patients from healthy controls. All involve a gene that codes for a subunit of NADH dehydrogenase – an important energy molecule.- MicroRNAs in spinal fluid predict orthostatic tachycardia after exercise.- No clear gene expression differences in ME/CFS v. healthy controls, at rest.

----------------

Energy Metabolism Studies- Studies on patients in the rituximab trial have an energy metabolism deficit, and the key molecule is the enzyme pyruvate dehydrogenase (PDH). Speculate that autoantiboedies may be the cause of this deficit. Upregulation of PDH inhibitors in white blood cells (Norway group – study will finish late 2017)- Peripheral white blood cells from ME/CFS produce energy less well than WBCs from healthy subjects, particularly when the cells are exposed to stressors.- Citric acid cycle metabolites are depleted. Glucose as an energy source is being replaced by fatty acids and amino acids- “Unbiased” metabolomics study finds that the metabolites that are most different between ME/CFS and healthy controls involve pathways harvesting energy from glucose, fatty acids and amino acids.- Also finds a general hypometabolic state, as did the recent paper from Naviaux (PNAS), though different metabolites were examined.

---------------------

Miscellaneous- ME/CFS patients, but not healthy controls, experience a worsening of symptoms following true (but not sham) strain: neuromuscular strain (even sitting/driving for prolonged time) may contribute to symptoms of ME/CFS. Physical therapy likely to help- Five specific findings on physical examination were quite accurate in diagnosing ME/CFS. This is of interest, since ME/CFS is defined exclusively by symptoms.- Of over 200 single-nucleotide polymorphisms examined, three – all located in the gene for NADH dehydrogenases – were significantly different in ME/CFS patients than in healthy controls.- ME/CFS patients have significantly higher anti-citrullinated protein antibodies than matched healthy controls, as is seen in the autoimmune whatever.- Particular mutations in two nucleosome transport genes distinguish ME/CFS patients from healthy controls.- A second case of ME/CFS caused by an enteroviral infection of the brain.- Impressive hypothesis: dysregulation in the production/release of Hydrogen Sulfide could explain many of the symptoms and objective abnormalities seen in ME/CFS- A subset of ME/CFS patients with sinusitis and/or hives has more pain and other symptoms

An ideal diagnostic test would:· Have very low false positive and false negative rates, compared to healthy controls and other fatiguing disease, when retested on a large number of new people· Be easy for perform reliably by many labs· Be inexpensive

Treatment Studies

· MRI spectroscopy revealed 15% lower levels of the natural antioxidant, glutathione, in the brain in ME/CFS patients compared to controls. N-acetyl-cysteine (NAC) treatment improved both brainglutathione levels and symptoms, and reduced oxidative stress, in the ME/CFS patients· Randomized trial of low-dose methylphenidate plus a nutritional regimen designed to improve mitochondrial function. At 12 weeks, a trend toward reduced symptom that was not statistically significant; more severely ill patients seemed to benefit· A careful study of 990 ME/CFS patients found that patient beliefs about the cause of their illness did not explain their level of activity, a result that does not support the theoretical benefit of cognitive behavioral therapy.· Multimodel physical therapy improves symptoms in adolescents and young adults with ME/CFS and impaired range of motion.· Quantitative modeling identifies drug that are already FDA-approved and that might target TNA-alpha, IL-2 and the glucocorticoid receptor – targets that may be important in causing the symptoms of GWI

Questions addressed by many presentations:· In an illness defined exclusively by subjective symptoms, is there evidence of underlying biological abnormalities?· Could those biological abnormalities theoretically explain the symptoms?· Do the abnormalities in fact correlate with the symptoms?

Author

PLEASE HELP PEOPLE WITH CFS/ME FIND THIS WEBSITE! Click "like" on any page. Thank you!

About me:I'm a 25-year veteran of CFIDS. I know what it is like to be bedbound for long stretches of time. I also know what it is like to recover, and to relapse. But this blog is not about my personal experience. It is intended to be a resource - a collection of anything that might be helpful to the CFIDS community: book reviews, advice, CFIDS news, research, advocacy, opinion, who's who in our community, fundraising... and occasionally a bit of humor.

Disclaimer: I am not a doctor, which means nothing I write, no matter how sensible it may be, should be interpreted as medical advice.